{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:10:11Z","timestamp":1792591811258,"version":"4.5.0"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Tuberculosis (TB) remains the primary cause of death among individuals infected with HIV, increasing the risk of contracting TB by up to 26 times. This co-infection complicates the diagnosis and treatment of TB, ultimately affecting outcomes adversely. Acute-phase proteins (APPs), markers of inflammation, are significantly elevated during infections and serve as critical indicators of inflammation resulting from infectious diseases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this prospective study, HIV-positive individuals at antiretroviral therapy (ART) clinics were screened for latent tuberculosis infection (LTBI) before starting isoniazid (INH) prophylaxis. Initially, 101 patients were enrolled, with 71 completing a six-month follow-up on INH prophylaxis. LTBI was diagnosed using QuantiFERON-TB Gold plus, categorizing participants as HIV-positive with LTBI (n=30) and HIV-positive without LTBI (n=71).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Plasma levels of alpha-2-macroglobulin (A2M), C-reactive protein (CRP), serum amyloid P (SAP), haptoglobin, ferritin, soluble transferrin receptor (sTFR), apotransferrin, hepcidin, and S100A8\/A9 were assessed using multiplex and quantikine assays.At baseline, levels of A2M, CRP, SAP, ferritin, hepcidin, and S100A9 were significantly elevated in HIV-positive patients with LTBI compared to those without LTBI (A2M, p=0.005; CRP, p&amp;lt;0.001; SAP, p=0.0006; ferritin, p&amp;lt;0.001; hepcidin, p=0.001; S100A9, p=0.001). Following six months of INH prophylaxis, significant reductions in these markers were observed in both groups, suggesting a reduction in inflammation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Our findings indicate that a baseline profile of APPs can effectively reflect the inflammatory status of HIV patients with LTBI. These inflammatory markers tend to decrease following effective INH treatment, underscoring their potential utility in monitoring disease progression and treatment response in this vulnerable population.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1551775","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T05:40:10Z","timestamp":1745991610000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Acute-phase proteins as biomarkers of inflammation in HIV patients with latent tuberculosis: a prospective study"],"prefix":"10.3389","volume":"16","author":[{"given":"Nathella","family":"Pavan Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajamariyam","family":"M","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arul","family":"Nancy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bubby S.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janakiram","family":"M","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaik Fayaz","family":"Ahamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijila","family":"S","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sekar","family":"S","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuralmozhi","family":"R","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhanaraj","family":"Baskaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed","family":"Hissar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subash","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"15035","DOI":"10.1038\/nrdp.2015.35","article-title":"HIV infection","volume":"1","author":"Deeks","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"B2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.5334\/aogh.4277","article-title":"Advancing the global fight against HIV\/aids: strategies, barriers, and the road to eradication","volume":"89","author":"Kumah","year":"2023","journal-title":"Ann Glob Health"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00042-10","article-title":"HIV and tuberculosis: a deadly human syndemic","volume":"24","author":"Kwan","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002464","article-title":"Tuberculosis and HIV co-infection","volume":"8","author":"Pawlowski","year":"2012","journal-title":"PLoS Pathog"},{"key":"B5","doi-asserted-by":"publisher","first-page":"10093","DOI":"10.1038\/s41598-019-46570-5","article-title":"A longitudinal study on latent TB infection screening and its association with TB incidence in HIV patients","volume":"9","author":"Wong","year":"2019","journal-title":"Sci Rep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2020.03.015","article-title":"Chronic immune activation in TB\/HIV co-infection","volume":"28","author":"Sharan","year":"2020","journal-title":"Trends Microbiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1186\/s12879-023-08505-4","article-title":"The metabolic consequences of HIV\/TB co-infection","volume":"23","author":"Herbert","year":"2023","journal-title":"BMC Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.4103\/0975-7406.76489","article-title":"Acute-phase proteins: As diagnostic tool","volume":"3","author":"Jain","year":"2011","journal-title":"J Pharm Bioallied Sci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2011.00002","article-title":"Mycobacterium tuberculosis infection and inflammation: what is beneficial for the host and for the bacterium","volume":"2","author":"Sasindran","year":"2011","journal-title":"Front Microbiol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00411","article-title":"The granuloma in tuberculosis: dynamics of a host-pathogen collusion","volume":"3","author":"Ehlers","year":"2012","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.731878","article-title":"Acute phase proteins are baseline predictors of tuberculosis treatment failure","volume":"12","author":"Kumar","year":"2021","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1471-2334-13-48","article-title":"Host iron redistribution as a risk factor for incident tuberculosis in HIV infection: an 11-year retrospective cohort study","volume":"13","author":"Mcdermid","year":"2013","journal-title":"BMC Infect Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(01)90328-1","article-title":"Serum C-reactive protein and detection of tuberculosis in persons co-infected with the human immunodeficiency virus","volume":"95","author":"Lawn","year":"2001","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-128-2-199801150-00009","article-title":"The pathophysiologic roles of interleukin-6 in human disease","volume":"128","author":"Papanicolaou","year":"1998","journal-title":"Ann Intern Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2005.08.007","article-title":"Serum amyloid P-component in murine tuberculosis: induction kinetics and intramacrophage Mycobacterium tuberculosis growth inhibition in vitro","volume":"8","author":"Singh","year":"2006","journal-title":"Microbes Infect"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201304-0803OC","article-title":"S100A8\/A9 proteins mediate neutrophilic inflammation and lung pathology during tuberculosis","volume":"188","author":"Gopal","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C114.598946","article-title":"Isoniazid induces apoptosis of activated CD4+ T cells: implications for post-therapy tuberculosis reactivation and reinfection","volume":"289","author":"Tousif","year":"2014","journal-title":"J Biol Chem"},{"key":"B18","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1186\/s12879-015-1201-8","article-title":"Effect of isoniazid preventive therapy on immune responses to mycobacterium tuberculosis: an open label randomised, controlled, exploratory study","volume":"15","author":"Biraro","year":"2015","journal-title":"BMC Infect Dis"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/bph.v176.24","article-title":"Isoniazid and host immune system interactions: A proposal for a novel comprehensive mode of action","volume":"176","author":"Khan","year":"2019","journal-title":"Br J Pharmacol"},{"key":"B20","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.876667","article-title":"The Iron Response of Mycobacterium tuberculosis and Its Implications for Tuberculosis Pathogenesis and Novel Therapeutics","volume":"12","author":"Rodriguez","year":"2022","journal-title":"Front Cell Infect Microbiol."},{"key":"B21","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1402351111","article-title":"Distinct patterns of hepcidin and iron regulation during HIV-1, HBV, and HCV infections","volume":"111","author":"Armitage","year":"2014","journal-title":"Proc Natl Acad Sci U S A."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1551775\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T05:40:12Z","timestamp":1745991612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1551775\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":21,"alternative-id":["10.3389\/fimmu.2025.1551775"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1551775","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"article-number":"1551775"}}